Trial: Evaluation of the effectiveness of two antiretroviral treatment strategies to prevent HIV transmission in HIV-serodiscordant couples [HPTN 052]
Phase: III
Product Being Tested: Highly active antiretroviral therapy for HIV prevention
Sponsor, funder, developer, collaborator:HIV Prevention Trials Network, Malawi College of Medicine-Johns Hopkins University, University of North Carolina Lilongwe
Total participants: 1,750 couples
Countries: Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, Zimbabwe
Trial sites in Malawi: Blantyre, Lilongwe
Results expected:
For more information: http://www.hptn.org/research_studies/hptn052.asp
Back to Top ↑